It's fair to say that Editas Medicine (EDIT 4.74%) is an ailing biotech. Over the past three years, its share price has fallen by 83% as it abandoned parts of its pipeline and laid off staff. Despite its supposedly powerful gene-editing technology, the company is struggling to advance its clinical programs to the point where they might be commercialized and generate revenue.Thankfully for Editas shareholders, Vertex Pharmaceuticals (VRTX 1.15%) just gave the business a much-needed break -- one that might ev ...

Editas Medicine, Inc. (NASDAQ:EDIT) EDIT-301 Program Update: RUBY and EdiTHAL Trials Data Update December 11, 2023 1:00 PM ET Company Participants Cristi Barnett - Corporate Communications & IR Gilmore O'Neill - CEO Baisong Mei - CMO Caren Deardorf - Chief Commercial & Strategy Officer Conference Call Participants Jack Allen - Baird Gena Wang - Barclays Joon Lee - Truist Securities Samantha Semenkow - Citigroup Yanan Zhu - Wells Fargo Luca Issi - RBC Capital Markets Phil Nadeau - TD Cowen Dae Gon Ha - Stife ...

Editas Medicine, Inc. (NASDAQ:EDIT) 6th Annual Evercore ISI HealthCONx Conference November 28, 2023 1:20 PM ET Company Participants Erick Lucera - CFO Cristi Barnett - Head, Corporate Communications & IR Conference Call Participants Liisa Bayko - Evercore ISI Liisa Bayko Thanks for joining us today for a fireside chat with Editas. My name is Liisa Bayko. I'm a biotech analyst at Evercore ISI, and I'm joined by the team here at Editas. So I'll just turn over. You can do some brief introductions and we'll the ...

Editas Medicine, Inc. (NASDAQ:EDIT) Stifel 2023 Healthcare Conference November 14, 2023 1:50 PM ET Company Participants Erick Lucera - EVP, CFO Cristi Barnett - VP, Corporate Communications and IR Conference Call Participants Dae Gon Ha - Stifel Dae Gon Ha Okay, let's go ahead and get started with the next session. Thanks everyone for joining us. For the next half hour or so, we're going to be talking Editas Medicine. My name is Dae Gon Ha, biotech analyst at Stifel. Joining me here on stage, we have Erick ...

Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Conference Call November 3, 2023 8:00 AM ET Company Participants Cristi Barnett - Corporate Communications & IR Gilmore O'Neill - CEO Baisong Mei - CMO Erick Lucera - CFO Linda Burkly - CSO Caren Deardorf - Chief Commercial & Strategy Officer Conference Call Participants Brian Cheng - J.P. Morgan Samantha Semenkow - Citi Joon Lee - Truist Securities Greg Harrison - Bank of America Gena Wang - Barclays Jack Allen - Baird Dae Gon Ha - Stifel Phil Nadeau - T ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ________ Commission File Number 001-37687 ______________ ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_2481022083899b1fd07c6210bb763944.html ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_d05160092a660d562f681583280b3081.html ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_ff79b632a4c1c83306ce6e7db9126fb9.html ...

Editas Medicine, Inc. (NASDAQ:EDIT) Q2 2023 Earnings Conference Call August 2, 2023 8:00 AM ET Company Participants Cristi Barnett - Corporate Communications & Investor Relations Gilmore O’Neill - Chief Executive Officer Baisong Mei - Chief Medical Officer Erick Lucera - Chief Financial Officer Conference Call Participants Terence Flynn - Morgan Stanley Samantha Semenkow - Citi Greg Harrison - Bank of America Joon Lee - Truist Securities Gena Wang - Barclays Dae Gon Ha - Stifel Yanan Zhu - Wells Fargo Rick ...